Home » News » Nephrology » Lupus Nephritis
Lupus Nephritis
Early diagnosis and treatment of childhood-onset systemic lupus erythematosus is important to prevent lupus nephritis outcomes such as end-stage kidney disease.
With further validation, the artificial neural network may be used in clinical practice for lupus nephritis management.
Exposure-adjusted incidence rates of serious adverse events 8.5 versus 11.2 per 100 patient-years for anifrolumab versus placebo
Both weight-based and non-weight-based low-dose HCQ associated with increased hospitalizations for SLE
Belimumab treatment continued to protect the kidneys in adults with active lupus nephritis.
One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.
Predictors of serious infection among patients with SLE were evaluated in a prospective study.
In a 5-year follow-up study, researchers identified the characteristics associated with cardiac function in patients with systemic lupus erythematosus.
The aim of the study was to evaluate the occurrence of SLE flares after COVID-19 vaccination.
In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.
Load More
Open
Next post in Lupus Nephritis
Close
Close more info about Childhood-Onset Lupus Nephritis Linked With Adverse Outcomes
Loading...
Close more info about Childhood-Onset Lupus Nephritis Linked With Adverse Outcomes
Loading...